脓毒症医嘱套餐使用与医疗价值提升相关
这项回顾性队列研究纳入某大型整合医疗系统2年内以脓毒症ICD-10编码出院的97,249例患者,52,793例(54%)接受了脓毒症医嘱套餐。经倾向性评分匹配后纳入55,542例(每组27,771例),医嘱套餐使用者住院死亡率降低3.3%,直接可变总成本中位数降低1,487美元(两者P<.01),代表医院收入及社会成本的中位付款方中性报销(PNR)降低465美元(P<.01),贡献边际增加1,022美元。作者认为,从医院和社会视角看,脓毒症医嘱套餐使用与医疗价值改善相关。
要点
- 在97,249例脓毒症住院患者中,52,793例(54%)接受了脓毒症医嘱套餐,倾向性评分匹配后每组27,771例。
- 医嘱套餐使用者住院死亡率降低3.3%(P<.01),直接可变总成本中位数降低1,487美元(P<.01)。
- 代表医院收入及社会成本的中位付款方中性报销(PNR)降低465美元(P<.01),贡献边际增加1,022美元。
- 作者认为,从医院和社会视角看,脓毒症医嘱套餐使用与医疗价值改善相关。
适用人群与场景
- 某大型整合医疗系统内2年间以脓毒症国际疾病分类第十版编码出院的患者。
研究设计与关键结果
- 回顾性队列研究,纳入97,249例脓毒症出院患者,其中52,793例(54%)接受脓毒症医嘱套餐。
- 倾向性评分匹配分析纳入55,542例,医嘱套餐组与无医嘱套餐组各27,771例。
- 医嘱套餐使用者住院死亡率降低3.3%(P<.01),直接可变总成本中位数降低1,487美元(P<.01)。
- 中位付款方中性报销(PNR)降低465美元(P<.01),贡献边际增加1,022美元。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,从医院和社会视角看,脓毒症医嘱套餐使用与医疗价值改善相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Sepsis is common and expensive, and evidence suggests that sepsis order sets may help to improve care. Very incomplete evidence exists regarding the effects of sepsis order sets on the value of care produced by hospitals or the societal costs of sepsis care.
RESEARCH QUESTION: In patients hospitalized for sepsis, is the receipt a of a sepsis order set vs no order set associated with improved value of care, defined as decreased hospital mortality, decreased hospital direct variable costs, and decreased societal spending on hospitalizations?
STUDY DESIGN AND METHODS: This retrospective cohort study included patients discharged with sepsis International Classification of Diseases, Tenth Revision, codes over 2 years from a large integrated delivery system. Using a propensity score, sepsis order set users were matched to nonusers to study the association between sepsis order set use and the value of care from the hospital and societal perspective. The association between order set receipt and hospital mortality, direct variable cost, and hospital revenue also were examined in a priori defined subgroups of sepsis severity and hospital mortality.
RESULTS: The study included 97,249 patients, with 52,793 patients (54%) receiving the sepsis order set. The propensity score match analysis included 55,542 patients, with 27,771 patients in each group. Recipients of the sepsis order set showed a 3.3% lower hospital mortality rate and a $1,487 lower median direct variable total cost (P < .01 for both). Median payer-neutral reimbursement (ie, PNR), a proxy for hospital revenue and thus societal costs, was $465 lower for sepsis order set users (P < .01). Receipt of the sepsis order set was associated with a $1,022 increase in contribution margin, the difference between direct variable costs and PNR per patient.
INTERPRETATION: Receipt of the sepsis order set was associated with improved value of care, from both a hospital and societal perspective.
参考来源
- Dale CR, Chiu ST, Schoepflin Sanders S, et al. Sepsis Order Set Use Associated With Increased Care Value. Chest. 2024. PMID: 38906463. doi:10.1016/j.chest.2024.05.032
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。